TABLE 3

Patient Characteristics and Results of Visual Analysis

					Minutes from injection to scanning		Image quality on 4-point scale		No. of detected lesions
Patient no.	Site	Sex	Age (y)	Disease	WB PET	fxPET	Reader 1	Reader 2	Gold standard	WB PET	fxPET
1	Neck	M	46	Bone tumor	52	96	2	2	3	3	3
2		M	59	Malignant lymphoma	58	110	2	2	8	7	6
3		M	66	Tongue cancer	50	92	2	2	1	1	1
4		M	76	Melanoma	54	121	2	2	2	2	2
5	Upper abdomen	F	65	Ovarian cancer	64	126	2	2	0	0	0
6		M	70	Pancreatic cancer	50	106	2	2	1	1	1
7		M	74	Hepatocellular carcinoma	62	99	2	2	1	1	1
8		M	77	Cholangiocarcinoma	62	104	2	2	5	4	4
9		F	62	Pancreatic neuroendocrine tumor	58	101	2	2	1	1	1
10		F	77	Pancreatic neuroendocrine tumor	49	111	2	2	4	1	1
11	Pelvis	F	66	Endometrioid cancer	62	108	3	3	4	4	4
12		F	30	Uterine cervical cancer	67	115	2	1	1	1	1
13		F	68	Uterine cervical cancer	66	132	2	2	6	6	6
14		F	52	Uterine cervical cancer	60	103	2	2	1	1	1
15		M	62	Rectal cancer	68	129	2	2	1	1	1
16	Musculoskeletal	M	73	Soft-tissue sarcoma	64	126	2	2	1	1	1
17		F	39	Soft-tissue sarcoma	60	161	2	2	1	1	1
Total		9 M, 8 F	62.5 ± 13.6^*		59.2 ± 6.2^*	114.1 ± 17^*	2^†	2^†	41	36	35